Condensed Statements of Changes in Shareholders’ Deficit (Unaudited) - USD ($)		Class A Ordinary Shares	Class B Ordinary Shares	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Jan. 06, 2025
Balance (in Shares) at Jan. 06, 2025
Class B ordinary shares issued to Sponsor	[1]		$ 767	24,233		25,000
Class B ordinary shares issued to Sponsor (in Shares)	[1]		7,665,900
Net income (loss)					(42,822)	(42,822)
Balance at Mar. 31, 2025			$ 767	24,233	(42,822)	(17,822)
Balance (in Shares) at Mar. 31, 2025			7,665,900
Balance at Dec. 31, 2025		$ 66	$ 767		(8,142,803)	(8,141,970)
Balance (in Shares) at Dec. 31, 2025		660,000	7,655,900
Accretion of Class A ordinary shares to redemption value					(2,041,625)	(2,041,625)
Net income (loss)					1,917,622	1,917,622
Balance at Mar. 31, 2026		$ 66	$ 767		$ (8,266,806)	$ (8,265,973)
Balance (in Shares) at Mar. 31, 2026		660,000	7,665,900

[1] Includes an aggregate of up to 999,900 Class B ordinary shares subject to forfeiture by the holders thereof depending on the extent to which the underwriters’ over-allotment option was exercised (Note 5). On May 27, 2025, the Company consummated its Initial Public Offering and sold 23,000,000 Units, including 3,000,000 Units sold pursuant to the full exercise of the underwriters’ option to purchase additional units to cover the over-allotment and as such 999,900 Class B ordinary shares are no longer subject to forfeiture.